Works matching DE "MYELOPROLIFERATIVE neoplasms"
Results: 2626
Ruxolitinib for Myelofibrosis: From 'Palliation' to Prolongation of Survival.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 717
- By:
- Publication type:
- Article
Improving Disease Burden in Myelofibrosis: Changing the Natural History of the Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 715
- By:
- Publication type:
- Article
Clarifying the Use of Ruxolitinib in Patients With Myelofibrosis.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 706
- By:
- Publication type:
- Article
HEMATOLOGY LETTERS FROM OMAHA: Revisiting the Role of Interferon Alfa-2 in the Treatment of Early Myelofibrosis.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 970
- By:
- Publication type:
- Article
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 10, p. 1221, doi. 10.1038/nsmb.2673
- By:
- Publication type:
- Article
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 8, p. 754, doi. 10.1038/nsmb.2348
- By:
- Publication type:
- Article
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 9, p. 971, doi. 10.1038/nsmb.2099
- By:
- Publication type:
- Article
Acute myeloid leukemia with 3q26 abnormality: An editorial perspective.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog<sup>*</sup> Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 312, doi. 10.1111/j.1476-5829.2011.00290.x
- By:
- Publication type:
- Article
Erythromelalgia Presenting with Premature Exfoliation of Primary Teeth: A Diagnostic Dilemma.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
- Published in:
- Nature, 2014, v. 512, n. 7512, p. 78, doi. 10.1038/nature13383
- By:
- Publication type:
- Article
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy.
- Published in:
- Nature, 2012, v. 489, n. 7414, p. 155, doi. 10.1038/nature11303
- By:
- Publication type:
- Article
The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 1, p. 150, doi. 10.3906/sag-2103-247
- By:
- Publication type:
- Article
Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency.
- Published in:
- Turkish Journal of Medical Sciences, 2019, v. 49, n. 5, p. 1560, doi. 10.3906/sag-1907-67
- By:
- Publication type:
- Article
The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients.
- Published in:
- Turkish Journal of Medical Sciences, 2019, v. 49, n. 1, p. 74, doi. 10.3906/sag-1803-13
- By:
- Publication type:
- Article
Polycythemia vera: diagnosis, clinical course, and current management.
- Published in:
- Turkish Journal of Medical Sciences, 2018, v. 48, n. 4, p. 698, doi. 10.3906/sag-1806-43
- By:
- Publication type:
- Article
JAK2 V617F mutation in Iranian patients with myeloproliferative neoplasms: clinical and laboratory findings.
- Published in:
- Turkish Journal of Medical Sciences, 2013, v. 43, n. 3, p. 347, doi. 10.3906/sag-1205-11
- By:
- Publication type:
- Article
Schizophrenia and Polycythemia Vera: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Special evolution in myelofibrosis – case reports.
- Published in:
- Oncolog-Hematolog, 2022, n. 61, p. 8
- By:
- Publication type:
- Article
Recurrent thrombosis onset in triple-negative essential thrombocythemia – more than a difficult diagnosis. Case report.
- Published in:
- Oncolog-Hematolog, 2021, n. 57, p. 48, doi. 10.26416/onhe.57.4.2021.5802
- By:
- Publication type:
- Article
Multi-Walled Carbon Nanotubes Accelerate Leukaemia Development in a Mouse Model.
- Published in:
- Toxics, 2024, v. 12, n. 9, p. 646, doi. 10.3390/toxics12090646
- By:
- Publication type:
- Article
A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs.
- Published in:
- Molecular & Cellular Oncology, 2021, v. 8, n. 2, p. 1, doi. 10.1080/23723556.2020.1871172
- By:
- Publication type:
- Article
Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk?
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 11, p. 4942
- By:
- Publication type:
- Article
Current status and hotspots evolution in myeloproliferative neoplasm: a bibliometric analysis from 2001 to 2022.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 10, p. 4510
- By:
- Publication type:
- Article
Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 22, p. 8451
- By:
- Publication type:
- Article
Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.
- Published in:
- Cells (2073-4409), 2014, v. 3, n. 2, p. 546, doi. 10.3390/cells3020546
- By:
- Publication type:
- Article
Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 644, doi. 10.3390/biom14060644
- By:
- Publication type:
- Article
Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 3, p. 262, doi. 10.1111/jcpt.12058
- By:
- Publication type:
- Article
A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone J. R. -Y. Wang et al. A case of myeloid neoplasm.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2010, v. 35, n. 6, p. 733, doi. 10.1111/j.1365-2710.2009.01130.x
- By:
- Publication type:
- Article
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1265022
- By:
- Publication type:
- Article
Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1276695
- By:
- Publication type:
- Article
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1277453
- By:
- Publication type:
- Article
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1277453
- By:
- Publication type:
- Article
Editorial: Case reports in hematological malignancies: 2022.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272547
- By:
- Publication type:
- Article
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1190305
- By:
- Publication type:
- Article
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1182971
- By:
- Publication type:
- Article
Epigenetics in myeloproliferative neoplasms.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1206965
- By:
- Publication type:
- Article
Myeloproliferative neoplasms - blurring the lines between cancer and chronic inflammatory disorder.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1208089
- By:
- Publication type:
- Article
Mutations, inflammation and phenotype of myeloproliferative neoplasms.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1196817
- By:
- Publication type:
- Article
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1176173
- By:
- Publication type:
- Article
Case Report: Infectious prophylaxis in hematological malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1163175
- By:
- Publication type:
- Article
Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1166163
- By:
- Publication type:
- Article
An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1109866
- By:
- Publication type:
- Article
Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97).
- Published in:
- Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1056786
- By:
- Publication type:
- Article
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.768592
- By:
- Publication type:
- Article
Symptom Burden Linked to Disability Leave Among Patients with Myeloproliferative Neoplasms.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 14
- Publication type:
- Article
Category VI: Research, Quality, Performance Improvement.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, n. 11, p. 539
- Publication type:
- Article
Thromboembolic Events in Myeloproliferative Neoplasms: Assessing Risk and Optimizing Value-Based Care.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2014, v. 5, p. S68
- By:
- Publication type:
- Article
Extramedullary hematopoiesis occurring as a nasal polyp in a man with myeloproliferative disorder.
- Published in:
- ENT: Ear, Nose & Throat Journal, 2004, v. 83, n. 4, p. 258, doi. 10.1177/014556130408300414
- By:
- Publication type:
- Article
Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
- Published in:
- Medical Oncology, 2007, v. 24, n. 1, p. 63, doi. 10.1007/BF02685904
- By:
- Publication type:
- Article